yngeal carcinoma in situ using the two biopsy techniques was also assessed.
Nasopharyngeal carcinoma in situ in nasopharyngeal carcinoma C W Chan, J M Nicholls, J S T Sham, P Dickens, D Choy Abstract Aims: To assess the presence of carcinoma in situ (CIS) in patients with nasopharyngeal carcinoma (NPC) and to see if the number of biopsy sites facilitates detection of CIS. Methods: Formalin fixed, paraffin wax embedded biopsy specimens (n = 285) from 187 patients with NPC in 1987 were studied for the presence of CIS as well as for the histological assessment of the subtype of CIS. Results: Fifteen (8.0%) patients had CIS, representing 8-3% of all new patients with NPC and 11*6% of patients with persistent disease or relapse. CIS was undifferentiated or poorly differentiated, no cases of well differentiated squamous celi CIS were identified. There was no significant difference in the incidence of CIS when multiple endoscopic biopsy specimens were taken rather than single forceps biopsy specimens. Conclusions: CIS can only be identified in a few patients with NPC largely because of late presentation with advanced disease at the time of diagnosis and the focal nature of the dysplastic process. The presence of dysplasia in relapses of NPC suggests that these tumours may be second growths rather than regrowths of a primary tumour. (7 Clin Pathol 1992; 45:898-901) yngeal carcinoma in situ using the two biopsy techniques was also assessed.
Methods
The slides of all biopsy cases diagnosed in 1987 as undifferentiated carcinoma, anaplastic carcinoma, and squamous cell carcinoma from the nasopharynx were retrieved and examined. If slides had faded they were restained and extra sections were cut if necessary. The specimens had all been fixed in 10% formalin, embedded in paraffin wax, and the slides stained with haematoxylin and eosin. The presence or absence of tumour was confirmed. Material from this period had been used in a previous study.4 If more than one biopsy specimen was taken from the nasopharynx during an examination it was classified as a multiple biopsy specimen. For the purpose of this study the presence of carcinoma in situ was characterised by the presence of cytological and architectural atypia affecting the whole thickness of the epithelium. Also assessed was whether such change was contiguous with the invasive tumour. The assessment was initially performed by one pathologist (iN). To On initial examination a total of 21 specimens from 18 patients had nasopharyngeal carcinoma in situ of which 15 were taken from primary growths and six were taken for the evaluation of relapse or persistent tumour. Following a review by the two other pathologists (PD, CWC) the distinction between in situ change and tumour replacement of the epithelium was considered too difficult to make in two cases from primary growths and in one from a recurrent tumour. These were excluded so that in the final analysis there were 15 patients with CIS-1 1 with primary growths and four with relapse. One patient had nasopharyngeal carcinoma in situ in the pre- Figure 2 Carcinoma in situ of an undifferentiated type (haematoxylin and eosin).
treatment biopsy specimens and in the recurrent tumour. CIS was therefore present in 8-0% of the patients with NPC. Eleven of 144 (7 6%) of all new patients with NPC had nasopharyngeal carcinoma in situ and five of 43 (11 6%) with relapse or persistent tumour showed the presence of nasopharyngeal carcinoma in situ. Of all the 219 multiple biopsy specimens, CIS was present in 14 (6 4%) and in four (6-1%) of the 66 single biopsy specimens. Two patients with both single and multiple biopsy specimens taken had CIS. There were no cases of well differentiated squamous cell CIS. Seven of our cases were of transitional or poorly differentiated type CIS (fig 1) and eight were analogous with an undifferentiated CIS using WHO criteria ( fig  2) , with an attenuated form of CIS identified (fig 3) . Continuity of the CIS with tumour could only be confirmed in six cases.
Discussion
There are many types of neoplasm which may arise in the nasopharynx and these reflect the variety of normal tissue elements in this region. The most common form of cancer in this area is NPC.5 The epithelial nature of this tumour has been well characterised by electron microscopy6 as well as by immunohistochemistry.'
There is little doubt that NPC originates in the epithelium of the nasopharynx even though continuity of tumour with the epithelium is not always seen. 8 Crypt epithelial cells may have a role in NPC as they have similar histological features to undifferentiated carcinoma. Though we detected no single criterion to differentiate dysplastic from normal epithelium, we found that in the latter condition the nuclear size and irregularity, prominence of nucleoli, decrease of lymphocyte numbers and absence of differentiation in the adjacent epithelium allowed attenuated dysplasia to be diagnosed in two cases.
There has been considerable disagreement and discussion on (8 6%) of CIS/microinvasive carcinoma among 1136 cases of NPC biopsy specimens.
The first article devoted entirely to nasopharyngeal carcinoma in situ was only published in 1986.12 The authors found an incidence of 2-3% in 2742 biopsy specimens, and of these, the abnormal cells occupied the whole thickness of the epithelium in 85A4% of cases while in 14-9% of cases the abnormal cells occupied only part of it. Most of the lesions were found in the surface epithelium while only 1 8-4% were seen in the crypt epithelium. In the cases of nasophryngeal carcinoma in situ there was significantly more nuclear DNA than in normal and metaplastic squamous epithelium.
In an initial report'3 and later in a monograph'4 Lee et al compared the nasopharyngeal in situ and premalignant lesions to those in the cervix and proposed the term nasopharyngeal intraepithelial neoplasia (NPIN), with three grades ranging from NPIN I to NPIN III. Their data showed that 73-3% of cases of NPC were NPIN and 12-3% of surgical biopsy specimens from the normal nasopharynx were NPIN. They also found NPIN in 1-5% of a series of necropsy cases. Our study is the first to use the multiple biopsy technique to look at the presence or absence of tumour and CIS. As Zong et al mentioned in their earlier paper, by the nature of its anatomical location the nasopharynx is not easily accessible and the same degree of accuracy cannot be applied to assessing nasopharyngeal carcinoma in situ as in the cervix.'2 Weiland also stated that the small size of biopsy material did not facilitate an accurate, consistent, and meaningful classification of NPC. Though no mention was made of the site of the biopsy in any of the preceding reports, we assume that they were taken straight from the tumour site and not adjacent to it. For the year studied, about 80% of the biopsy specimens for the initial assessment of NPC were multiple; for relapses the single biopsy specimens detected 33%. This is because the pretreatment multiple biopsy technique was considered at that time to be important in the staging of the tumour17 and the posttreatment biopsy specimen was just to document the presence or absence of tumour. We found CIS in 6-8% of the multiple biopsy specimens and in 6-1% of the single specimens; this difference was not significant. The multiple biopsy technique may be advantageous for staging purposes but it does not promise better detection of CIS.
The prevalence of nasopharyngeal carcinoma in situ associated with invasive NPC is much less than CIN which has been used by some as a model for the nasopharynx. We attribute this to two reasons: first, we were unable to visualise the nasopharynx in as great a detail as the cervix. Secondly, and more importantly, NPC tends to present at a later stage than carcinoma of the cervix and most of the biopsy specimens of tumour do not show sufficient epithelium because this has been replaced by tumour. It should also be appreciated that CIS is an evolving lesion and the biopsy specimen represents one stage in the developing lesion. The tumour is also different from the cervical lesion in that it does not appear to go through all the stages of CIS before frank invasion develops. In this respect it is perhaps better to think of the nasopharyngeal mucosa as being more similar in behaviour to bladder rather than cervical mucosa.
One very interesting point of our study was that five cases of nasopharyngeal carcinoma in situ were found among the cases of relapse or disease persisting 12 weeks after radiotherapy had been completed. Four of these cases were in relapse while one was persistent disease. If the case of persistent disease is removed, there were four cases occurring in 24 patients with relapse (16-7%), a figure higher than that of the primary cases. Traditionally, relapse has been considered regrowth of tumour that has not been eradicated, but our findings suggest that it could represent a second growth. Further study is being conducted in this area.
